Ingenuity Systems said this week that it is collaborating with Sage Bionetworks to improve the non-profit's predictive disease networks.
Under the collaboration, Sage will use the company's Ingenuity Pathway Analysis software and Ingenuity Knowledge Base to improve its predictive disease networks. In addition, Sage's web portal will link out to the Ingenuity Knowledge Base and to IPA, and Sage's content, algorithms, and predictive disease networks will be made available within Ingenuity products like IPA.
Ingenuity said that the collaboration will be of particular interest to researchers "who are working to understand the complex developments in the diagnosis, treatment, and etiology of diseases." In particular, using Sage's content and algorithms within IPA will enable users "to more rapidly identify and prioritize therapeutic targets for drug development and assess toxicity of potential drug candidates," the company said.
The collaboration with Sage marks the third partnership that Ingenuity has signed within the last month. In late October, the company announced that it was going to integrate IPA with TransMed Systems' XB Bio-Integration Suite (BI 10/22/2010). In early November, it announced an agreement with Geospiza to integrate IPA with Geospiza's Genesifter (BI 11/5/2010).